Some months after the first Covid-19 vaccines became available, the World Health Organization (WHO) set a target of vaccinating 70% of each country’s population by the end of June 2022. Global trends indicate that initially, a slow supply did not allow African countries, in particular, to stay on pace to meet this target, and now vaccination rates have even begun to slow down. Given the deadline, we explore the current relevance and achievability of the WHO’s target, and why it proved challenging for some developing nations in Africa.  

Also in this issue, we take a look at efforts to tackle the opioid epidemic and how small biotechs and research labs appear to be at the forefront of innovative research in that domain.  

Don’t miss the data-led investigations into the demand for jobs in cybersecurity and big data in the pharmaceutical industry, and how artificial intelligence-led efforts in drug discovery may still only be at the start of a long development journey.  

All this, and the latest pharma industry news, comment, data and analysis from GlobalData. 

Manasi Vaidya, editor

Go to article: Home | How delays derailed Covid-19 vaccination in AfricaGo to article: In this issueGo to article: ContentsGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: SHL MedicalGo to article: Stormy StudioGo to article: CommentGo to article: It will take years for AI use to peak in drug discovery and development processGo to article: Bear market hits Europe’s innovator drug venture financing, losing pace with USGo to article: Longevity technology and its futureGo to article: Potential impact on women’s healthcare post-Roe versus WadeGo to article: Dupixent approval brings first biologic to youngest atopic dermatitis patientsGo to article: BioLife SolutionsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: How delays derailed Covid-19 vaccination in AfricaGo to article: Is pharma doing enough to tackle the opioid epidemic?Go to article: Decoding the Covid-19 connection with diabetesGo to article: CAR-Ts in China: the dawn of an immunotherapy superpowerGo to article: Drawing on data to make oncology trials diverseGo to article: NiproGo to article: BEA TechnologiesGo to article: In DataGo to article: The pharmaceutical industry found it harder to fill cybersecurity vacancies in Q1 2022Go to article: Debt offerings decreased significantly in the pharmaceutical industry in H2 2021Go to article: Partnerships decreased in the pharmaceutical industry in H2 2021Go to article: Europe is seeing a hiring boom in pharmaceutical industry big data rolesGo to article: EventsGo to article: Next issue